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Abstract Rationale: Nicotine and alcohol are frequently
co-used, suggesting that use of one drug may facilitate use
of the other. Furthermore, because men and women differ
in their responses to both drugs, it is possible that men and
women also differ in their responses to the combination of
nicotine and alcohol. Objective: This experiment was
designed to investigate the effects of nicotine on con-
sumption and subjective and physiological effects of
alcohol in healthy male and female social drinkers.
Materials and methods: Healthy light smoking, social
drinkers (22 men and 12 women) participated in a three-
session, double-blind within-subject study. They were
pretreated with transdermal nicotine (7 or 14 mg) or
placebo, followed two h later by an alcoholic beverage,
and subsequent opportunities to “purchase” and consume
more of the same drink. Outcome measures included the
number of alcoholic beverages consumed and subjective
and physiological effects. Results: Nicotine increased
alcohol consumption in men, whereas it decreased alcohol
consumption in women. These effects were even more
pronounced after excluding participants reporting nausea
after nicotine administration. Nicotine alone increased
subjective arousal in men but decreased positive mood in
women. Nicotine increased the sedative-like effects of
alcohol in both sexes. Conclusions: These findings
indicate that both the subjective effects of nicotine and
the effects of nicotine on alcohol consumption differ
markedly in men and women. The findings extend existing
data on sex differences in the effects of either nicotine or
cigarette smoking on alcohol consumption, and support
the idea that the pharmacological effects of nicotine may
differ in men and women.
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Introduction
Nicotine and alcohol are often used together. Smoking
tobacco is common in settings where alcohol is consumed
(Siegel and Skeer 2003), and individuals who habitually
use one substance are likely also to use the other (Zacny
1990). For example, 80–90% of smokers regularly drink
alcohol, compared to 66% of the general population, and
smokers tend to be heavier drinkers than non-smokers
(Friedman et al. 1974; Strine et al. 2005). Conversely, 80%
of alcoholics smoke, compared to only 23% smokers in the
general population (Miller and Gold 1998; NCHS and
CDC 2004). Recently, Dierker et al. (2006) reported a high
proximal association between smoking and drinking
among 225 first-year-college students, using weekly
follow-back diaries over 7 months. Their results confirm
that occasional users of both drugs are much more likely to
smoke when they drink, and to drink when they smoke.
The reasons for the high prevalence of co-use of tobacco
and alcohol are not fully understood. The co-use may
reflect preexisting risk factors in certain individuals, or it
may reflect environmental factors that facilitate the use of
both drugs. Alternatively, co-use could also result from a
pharmacological interaction between nicotine and alcohol,
such that use of one drug facilitates use of the other. That is,
alcohol may facilitate smoking, or nicotine may facilitate
drinking. Indeed, there is experimental evidence that
ethanol increases the reinforcing properties of tobacco
smoking and nicotine (i.e., Griffiths et al. 1976; Mintz et al.
1985; Mitchell et al. 1995; Rose et al. 2004), and there is
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limited evidence that nicotine may increase the reinforcing
value of ethanol (Barrett et al. 2006; Perkins et al. 2000;
Potthoff et al. 1983; Smith et al. 1999).
Studies with both non-humans and humans support the
idea that nicotine increases consumption of alcohol. Potthoff
et al. (1983) found that rats implanted with chronic slow
nicotine release devices consumedmore ethanol than control
animals. This intake was not due to increased calorie
seeking; several other abused drugs failed to increase ethanol
intake. Other studies have shown that nicotine increases
ethanol consumption in both ethanol-preferring and normal
strains of rats, and after subchronic or acute administration of
nicotine (Blomqvist et al. 1996; Le et al. 2000; Smith et al.
1999). Interestingly, male alcohol-preferring (Prats) also
self-administer both nicotine and sucrose more readily than
non-preferring (NP) rats, although the P and NP animals do
not differ in cocaine self-administration (Le et al. 2006). In
humans, Perkins et al. (2000) reported that male smokers
consumed less alcohol after abstaining from smoking
overnight, compared to normal smoking, and that alcohol
produced more sedative effects after smoking abstinence.
These findings are consistent with the idea that nicotine
enhances the reinforcing effects of ethanol, but the study
lacked a placebo control, and acute withdrawal could also
have played a role in reduced alcohol consumption.
Kouri et al. (2004) recently reported that transdermal
nicotine (21 mg) increased participants’ reports of feeling
the effects of ethanol (0.4 and 0.7 g/kg), feeling drunk
and feeling euphoric. Nicotine also increased the desire to
drink and smoke in these moderate, non-dependent male
smokers. This pattern of subjective responses suggested
that nicotine might have also increased alcohol consump-
tion if the participants had been given the opportunity to
drink. Barrett et al. (2006) found that nicotinized, but not
denicotinized, cigarettes increased motivation among
male, non-dependent smokers to consume alcohol (com-
pared to water), using a progressive ratio schedule. Finally,
the nicotinic antagonist, mecamylamine, dampens the
subjective and perhaps the reinforcing effects of alcohol
(Blomqvist et al. 2002; Chi and de Wit 2003). Thus, evi-
dence in both laboratory animals and humans suggest that
nicotine enhances the reinforcing effects of alcohol.
One important limitation of the two recent studies on the
effects of nicotine on responses to alcohol (Barrett et al.
2006; Kouri et al. 2004) is that they were conducted using
only men. There is evidence that there are sex differences
in responses to nicotine (Perkins et al. 2002) as well as to
the nicotinic antagonist mecamylamine (Chi and de Wit
2003; Young et al. 2005). Perkins et al. (2002) found that
the pharmacological effects of nicotine play a more im-
portant role in smoking behavior among men, whereas,
women are more reactive to sensory smoking cues. Perkins
(1999) also found that women were less sensitive to
changes in dose of a nicotine nasal spray. More recently,
Chaudhri et al. (2005) have also reported sex differences in
the reinforcing effects of nicotine in rats. Chi and de Wit
(2003) found that mecamylamine attenuated the positive
subjective effects of alcohol and self-reported desire to
drink more in men than in women (but see also Blomqvist
et al. 2002). These findings suggest that the effects of
nicotine on alcohol responses or consumption may differ in
men and women.
In the present study, 34 social-drinking light smokers
(“chippers”) participated in three sessions in which they
were pretreated with placebo or nicotine (7 or 14 mg)
patches. Participants consumed one required ‘priming’
dose of alcohol (0.2 g/kg; 2.75 h after nicotine), and then
had opportunities to consume up to eight additional doses
of alcohol over the next 2 h (0.1 g/kg each). We used a
sensitive procedure for examining changes in alcohol
value, which used individualized drink values and system-
atically varied drink prices (Young et al. 2005). We
hypothesized that nicotine would increase the euphorigenic
effects of the required dose of alcohol, and increase the
number of drinks consumed. Based on the Perkins et al.
(2002) findings that men are more sensitive to the phar-
macological effects of nicotine, we further expected that




Twenty-two male and 12 female social drinkers, aged 21 to
41, who smoked between one and ten cigarettes per day,
participated. Light smokers were recruited to reduce the
influence of nicotine withdrawal on placebo sessions.
Participants were recruited from the university and sur-
rounding communities through posters, newspaper adver-
tisements, and word-of-mouth referrals. Initial eligibility
was ascertained during a telephone interview screening
process. Potential participants underwent further screening
by completing a psychiatric symptom checklist (SCL-90;
Derogatis 1983), the Michigan Alcoholism Screening Test
(MAST; Selzer 1971), and a detailed health and drug-use
questionnaire.
Screening included a semi-structured psychiatric screen-
ing interview based on the Structured Clinical Interview for
DSM-IV Disorders (SCID; First et al. 1996), an electrocar-
diogram, and a physical examination. Inclusion criteria were:
(1) consuming four or more alcoholic drinks per week, and
two or more on one occasion, (2) regularly smoking one to
ten cigarettes per day, (3) having a high school diploma or
equivalent, (4) having a body mass index value between 19
and 26 kg/m2. Exclusion criteria included any current
medical condition requiring medication, history of or current
Axis I psychiatric diagnoses (DSM-IV-TR; APA 2000),
history of or current substance-use disorder, lack of fluency
in English, cardiovascular disease, high or low blood
pressure, or abnormal electrocardiogram. Women were
excluded if theywere pregnant, planning to become pregnant,
breast-feeding, or had severe premenstrual symptoms.
Subjects signed informed consent before participating.
For blinding purposes, they were told that they might
receive one or more of the following drugs: stimulant,
sedative, antihistamine, beta-blocker, alcohol, or placebo.
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Participants were instructed not to consume any drugs other
than their usual amounts of caffeine and nicotine for 24 h
prior to and 12 h after each of the study sessions, and to fast
beginning at noon on session days. These procedures were
approved by the Institutional Review Board at the University
of Chicago.
Design
The study used a double-blind, within-subjects, placebo-
controlled design. Each subject participated in three 6.5-h
experimental sessions, separated by at least 72 h. During
the sessions, participants received a patch containing either
placebo or nicotine (7 or 14 mg; Nicoderm CQ;
GlaxoSmithKline). Two hours and 45 min after the patch
was administered, participants consumed a required,
priming dose of alcohol (0.2 g/kg) over 5 min, and
10 min later completed self-report questionnaires. This
time course was selected to correspond with peak plasma
levels of nicotine after patch administration (Gorsline et al.
1992). Thirty minutes later, a 2-h drink choice period
began, during which participants had opportunities to
purchase and consume eight additional, optional 0.1-g/kg
alcoholic beverages, one every 15 min. The price of the
beverages varied across the opportunities, as described below.
The primary dependent measure was the number of beverages
each subject consumed during the 2-h choice procedure.
Secondary measures included self-report measures of mood
states, temperature, blood alcohol level, and cardiovascular
measurements of blood pressure and heart rate.
Laboratory environment
The study was conducted in a recreational laboratory
environment in the Human Behavioral Pharmacology Lab-
oratory in the Department of Psychiatry at the University of
Chicago Hospital. The environment resembled a living room,
with upholstered chairs and sofas, incandescent lighting,
decorated walls, tables with magazines, board games, and
video entertainment units. Participants were tested in small
groups of two to four individuals.Womenwere tested without
regard to menstrual cycle phase because menstrual cycle
phase does not strongly influence responses to either nicotine
or alcohol Terner and de Wit (2006). During times when
participants were not participating in tasks or completing
questionnaires, they were allowed to relax, read magazines,
play games, watch videos, and interact with other group
members, but were not allowed to study or work.
Session procedures
For each experimental session, participants arrived at the
laboratory at 1:30 P.M. (i.e., at −30 min or 30 min before
patch administration). First, they provided breath and urine
samples to verify compliance with drug abstinence in-
structions. Participants then relaxed for 10 min to stabilize
subjective and physiological measures, and at 1:40 p.m.
(−20 min) they completed baseline self-report question-
naires (see below), and temperature, heart rate, and blood
pressure were measured. At 2:00 P.M. (0 min), a research
assistant who was blind to the conditions placed a patch
containing placebo or nicotine (7 or 14 mg). For the next
120 min participants relaxed to allow for drug absorption,
and completed subjective ratings at 60 and 120 min. These
ratings were used to assess the direct effects of the nicotine.
At 4:45 p.m. (165 min), participants consumed the required
alcoholic beverage (0.2 g/kg) within 5 min. Ten minutes
later they completed questionnaires which were used to
assess the combined effects of alcohol and nicotine.
At 5:00 P.M. (180 min), the 2-h choice procedure began
during which participants could “buy” single drinks (0.1
g/kg ethanol) every 15 min for 2 h. Participants bought
the drinks using tokens of varying, and individualized,
value (see below). At 7:05 P.M. (305 min), immediately after
the drinking period, subjective, behavioral, and physiolog-
ical measures were taken. At 8:00 P.M. (360 min), before
leaving the laboratory, participants completed a final
questionnaire reporting how much they liked or disliked,
overall, what they consumed. After completing all three
sessions, participants were debriefed and paid for their
participation. They were transported home provided that
their BAL was below 0.04 dl/l.
Drink valuation and token procedure
During an orientation session before the first session, each
subject completed a brief computerized questionnaire to
estimate how much he or she valued an alcoholic drink.
The questionnaire, consisting of systematic choices of
money vs a drink, provided an equivalent monetary value
for a standard alcoholic beverage (a can of beer, a glass of
wine, one shot of liquor, etc), i.e., a value at which the
subject was equally likely to choose the drink or the money.
This personal drink value was used to set the ‘cost’ of
optional drinks in the subsequent testing sessions.
At the beginning of each testing session, participants
received 36 tokens, each worth 1/8 of the subject’s
estimated personal drink value for a standard drink. During
the choice phase, participants were offered eight optional
drinks, each containing 0.1 g/kg ethanol, about half a
standard alcoholic drink. Therefore, each optional drink
should have been worth about four tokens. Participants
were told that they could “buy” drinks with tokens every
15 min over the next 2 h, and that any tokens left unspent
would be redeemed for cash at the end of the session.
Participants made their choices of beverage (or money)
privately to reduce the possible influence of the group on
beverage choices.
For each choice, the experimenter escorted the subject to
another room and informed him of the price of the next
drink. On four of the drink options, drinks were priced at
four tokens, on two options they were “cheap” (two tokens)
and on another two they were “expensive” (eight tokens).
The cost of the drink was varied across trials to test for
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potential effects of nicotine on cost/benefit considerations
in drink choices, to test the sensitivity of our procedure
(choice should be related to price), and to deter participants
from planning drink decisions before purchase opportu-
nities. Drink prices were presented in one of two orders
over the eight drink options: four, two, eight, four, four,
eight, two, and four, or four, eight, two, four, four, two,
eight, and four tokens. These orders were alternated across
sessions to further prevent participants from anticipating
upcoming drink prices.
Drug preparation
Nicoderm CQ (GlaxoSmithKline, Research Triangle Park,
NC, USA) patches containing 7 or 14 mg of nicotine
were used. Placebo patches were the same in size and color
and contained a small amount of capsaicin (0.075%)
analgesic cream to match the tingling sensation of nicotine
on the skin. Active and placebo patches were covered with
medical adhesive tape to blind the participants and the
research assistant.
Ethanol (Everclear 95%) was mixed with pulp-free,
Minute Maid brand orange juice to a concentration of 16%
ethanol. The doses were 0.2 g/kg (required dose) and 0.1
g/kg (optional dose). Ethanol doses administered to women
were 10% lower to account for sex differences in body
composition (Breslin et al. 1997). The beverages were
served cold in styrofoam cups.
Dependent measures
The primary dependent measure was the number of
beverages consumed. Beverage choices were examined in
relation to nicotine dose, price, and sex. Secondary mea-
sures included self-report measures of drug effects, in-
cluding the Stimulant and Sedative scales of the Biphasic
Alcohol Effects Scale (BAES; Martin et al. 1993), the Drug
Effects Questionnaire (DEQ; Johanson and Uhlenhuth
1980), the Addiction Research Center Inventory (ARCI;
Martin et al. 1971), the Profile of Mood States (POMS;
McNair et al. 1971), and the Visual Analogue Scale (VAS;
Folstein and Luria 1973). Physiological measures included
blood pressure, heart rate, temperature, and blood alcohol
concentration. These measures were used to assess the
effects of nicotine (pre-beverage), and the interaction
between nicotine and alcohol (post-beverage).
Subjective drug effects
The Biphasic Alcohol Effects Scale (BAES; Martin et al.
1993) is a 14-item self-report adjective rating scale that is
sensitive to the stimulant and sedative effects produced by
ethanol. Participants indicate the extent to which they feel
each of the 14 adjectives on a 10-point scale from “not at
all” (0) to “extremely” (10).
The Drug Effects Questionnaire (DEQ; Johanson and
Uhlenhuth 1980) consists of four questions concerning
current drug effects. Participants indicate on 100-mm lines
whether they: 1) are currently feeling any drug effects
(from “none” to “a lot”), 2) like the effects they feel
(from “not at all” to “very much”), 3) are high (from “not at
all” to “very”), and 4) want more of the drug (from “not at
all” to “very much”).
The Addiction Research Center Inventory (ARCI;
Martin et al. 1971) is a 49-item true–false questionnaire
sensitive to the effects of five drug classes. This version has
five empirically derived scales: Amphetamine (A) and
Benzedrine Groups (BG), which are indices of stimulant-
like effects; the Morphine–Benzedrine Group (MBG),
which is a measure of euphoria; the Pentobarbital–Chlor-
promazine–Alcohol Group (PCAG), which is an index of
sedation; and Lysergic Acid Diethylamide (LSD), which is
a measure of dysphoric and somatic symptoms.
The Profile of Mood States (POMS; McNair et al. 1971)
consists of a 72-item self-report, multiple choice, adjective-
rating system. Participants indicate the extent to which they
are feeling each of the 72 adjectives on a five-point scale
from “not at all” (0) to “extremely” (4) that best relates to
how much they are feeling that particular adjective. The
answers to these questions are then organized into eight-
factor-analyzed scales: “friendliness”, “anxiety”, “depres-
sion”, “fatigue”, “anger”, “elation”, “confusion”, and
“vigor”, and two composite scales, “arousal” and “positive
mood”.
The Visual Analogue Scale (VAS; Folstein and Luria
1973) consists of eight adjectives used to describe current
drug effects. Participants mark on 100-mm lines whether
they feel “stimulated”, “high”, “sleepy”, “anxious”,
“elated”, “nauseated”, “sedated”, and “hungry”.
Physiological measures
Heart rate and blood pressure were measured using a
Dinamap vital signs monitor Model 1846 (Criticon,
Tampa, FL, USA). Temperature was measured orally by
a digital IVAC TEMP-PLUS II thermometer (Alaris
Medical Systems, San Diego, CA, USA). Breath alcohol
level was measured by using digital Alco Sensor
(Intoximeters, St. Louis, MO, USA).
Data analysis
The primary outcome measure was the number of alcoholic
beverages chosen during the 2-h choice period. These
choice data were analyzed using repeated measures
ANOVA with dose of nicotine as a within-subject factor
and sex as a between-subject factor. In separate analyses,
drink price (two, four, or eight tokens) was also entered
into the analysis with both dose and drink price as
within-subject factors and sex as a between-subject factor.
Because a substantial number of participants reported
feeling nauseous after nicotine, the choice data were
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analyzed separately for those individuals who did not
report more than a 10% increase in nausea on the VAS scale
at either dose of nicotine. Nine men and five women
reported feeling nauseous, mostly after the 14-mg dose.
Fisher-protected least significant difference (LSD) was
used for all post hoc analyses.
Subjective, physiological, and behavioral measures were
examined to assess the direct effects of nicotine and of the
interactions between nicotine and alcohol. To assess the
effects of nicotine, we utilized measures obtained before
and 120 min after administration of the patch (placebo, 7
and 14 mg nicotine). After verifying that there were no
spurious pre-patch differences across the nicotine condi-
tions, we calculated change from baseline (i.e., pre-patch to
120 min) scores for each measure. These change scores
were analyzed using two-way repeated measures (ANO
VAs; dose, sex) for each outcome measure. To assess the
interaction between nicotine and alcohol, we compared
participants’ ratings after they consumed the required
beverage (i.e., before the choice phase) in the three nicotine
pretreatment conditions (two-factor ANOVA; dose, sex).
The last measure of subjective effects was not included in




One subject tested positive for cocaine and was dropped
from the study. The demographic characteristics of the
remaining participants in the study are summarized in
Table 1. Most participants were in their mid-20s, they
consumed on average one to two drinks per day and
smoked about two to three cigarettes per day. Expired
carbon monoxide readings averaged across sessions ranged
from 1.33 to 12 ppm (mean±SD 2.9±3.2). Male partici-
pants were significantly older and heavier than females,
and a higher proportion of the men reported having tried
hallucinogens. Female participants consumed more caffein-
ated beverages.
Determination of alcohol value
The monetary values judged to be equivalent to a standard
drink, as determined during the orientation session, varied
among males from $0.20 to $2.44 (mean±SD $0.97±$0.15)
and among females from $0.50 to $2.96 (mean±SD $1.47±
$0.25). The mean monetary values did not significantly
differ in men and women, and the individual monetary
values were not related to the number of drinks participants
chose in the choice phase of the study.
Effects of nicotine on alcohol choice
Nicotine had differential effects on alcohol consumption in
men and women. In all participants (n=33), nicotine tended
to increase alcohol consumption in men but tended to
decrease in women [dose by gender interaction; F(2, 62)=
2.982, p=0.058; Fig. 1a]. However, nicotine produced
nausea and vomiting in some participants (see below),
which could have influenced alcohol choice. Therefore, we
also examined choice among participants who did not
report significant nausea, defined as less than a 10% in-
crease on ratings of nausea at either dose of nicotine. Using
this criterion, we analyzed the alcohol consumption data
for 12 men and 7 women. In this analysis, nicotine
produced opposing effects on alcohol consumption in men
and women [dose by gender interaction; F(2, 34)=4.966,
p=0.013; Fig. 1b]. LSD tests revealed that nicotine (14 mg)
significantly increased alcohol consumption in men rel-
ative to placebo and relative to women after nicotine (7 and
14 mg). In contrast, nicotine (14 mg) decreased alcohol
consumption in women relative to placebo.
Interactions between choice and price
Alcohol choice was also examined in relation to the price
(in tokens) of each drink, using only those individuals in
whom nicotine did not produce nausea. Overall, alcohol
Table 1 Demographic characteristics of all participants, including
those who did and did not experience nausea
Males (n=21) Females (n=12)
Age (years: mean±SD) 27.6±5.1 22.9±2.0*
Weight 165.4±17.3 136.7±21.0*







Some college 10 7
College degree 7 3
Advanced degree 4 2
Current drug use (mean±SD)
Alcohol (drinks/week) 12.2±10.6 7.5±3.90
Cigarettes (cigs/week) 18.9±19.1 13.8±12.3
Caffeine (cups/day) 1.3±0.8 3.2±3.1*






aOne male identified himself as Caucasian and Hispanic, and one
female identified herself as Black and Hispanic
*=p<0.01
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choices were inversely related to price [F(2, 34)=27.411,
p<0.001]. Participants, on average, chose drinks 74.2% of
the time when drinks were priced at two tokens, 53.8% of
the time at four tokens, and 27.5% of the time at eight
tokens. This orderly relationship indicated that our pricing
procedure (Young et al. 2005) is valid and confirms the
sensitivity of the procedure to interventions. Nicotine did
not differentially affect alcohol choice depending on the
price (i.e., no price-by-dose or price-by-dose-by-gender
interaction). However, inspection of the means shown in
Fig. 2 suggested that there were differential effects of
nicotine on price in men and women. LSD analysis re-
vealed that nicotine (14 mg) significantly increased drink
choices at the eight-token price in men, whereas, it
significantly decreased choices at the two-token price in
women.
Effects of nicotine alone
In the full group of 33 participants, nicotine (14 mg)
markedly increased VAS ratings of nausea (mean±SD
placebo 0.029±0.08, nicotine 7 mg 0.032±0.09, and
nicotine 14 mg 0.156±0.26). Three women vomited after
Table 2 Effects of nicotine
Placebo 7 mg nicotine 14 mg nicotine
DEQ-like 0.001±0.023 0.029±0.021 −0.085±0.046*
VAS high 0.064±0.020 0.031±0.034 0.088±0.039*





Mean (±SEM) ratings of drug liking, feeling high, anxiety and
systolic blood pressure in participants who did not report increases
in nausea after nicotine. Values represent mean change from pre- to
120 min post-patch. Possible values for DEQ and VAS change
scores range from −1.0 to 1.0. Possible values for POMS change
scores range from −4.0 to 4.0. Significant main effects (ANOVA)
were obtained on each measure
*Significant (p<0.05) difference from placebo, based on LSD test
Fig. 1 Mean±SEM percent of available drinks chosen after placebo
(PL), 7 mg and 14 mg nicotine (NIC). Upper panel shows effects of
nicotine on all participants (n=21 males, 12 females). Lower panel
shows only the participants who were not made nauseous by
nicotine administration (n=12 males, 7 females). Note mean number
of drinks chosen rather than percent available chosen was compared
for statistical analysis. *indicates significant difference from place-
bo. # Indicates significant difference between men and women
Fig. 2 Mean±SEM percent of available drinks chosen at the two-
token (“cheap”), four-token (self-rated value), and eight-token
(“expensive”) choice conditions after placebo, 7 mg, and 14 mg
nicotine in only those participants not made nauseous by nicotine
administration. Males (n=12) are shown in the upper panel (a) and
females (n=7) are shown in the lower panel (b). In both sexes,
choice was inversely related to price. Note mean number of drinks
chosen rather than percent available chosen compared for statistical
analysis. *indicates significant difference between placebo and
14 mg nicotine
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receiving the 14-mg patch. Reports of nausea were not
related to habitual smoking, weight, BMI, sex, or race.
The direct effects of nicotine were further examined
using only those participants who reported no nausea at
either dose. Table 2 depicts significant main effects of
nicotine in these participants (12 men, 7 women). Nicotine
(14 mg) significantly decreased DEQ ratings of “Liking”
the drug effect [F(2, 34)=4.84, p=0.014] and increased
ratings of “High” (VAS) [F(2, 34)=4.35, p=0.021], and
“Anxiety” (POMS) [F(2, 34)=3.69, p=0.035]. Nicotine
(7 mg) significantly increased systolic blood pressure [F(2,
34)=3.35, p=0.047], but nicotine did not affect diastolic
blood pressure, heart rate, or temperature. The only
significant differences between men and women were on
“Arousal” and “Positive Mood” (POMS). Nicotine (14 mg)
increased “Arousal” in men and not women [F(2, 34)=
3.44, p=0.044; Fig. 3]. LSD tests revealed that after
nicotine (14 mg), ratings of “Arousal” were significantly
greater compared to placebo and compared to women after
14 mg nicotine. In contrast, nicotine decreased “Positive
Mood” ratings in women but not men [F(2, 34)=7.24,
p=0.014; Fig. 4]. LSD tests revealed women had
significantly higher ratings of “Positive Mood” than men
at placebo and 7 mg nicotine, and women had significantly
lower ratings of “Positive Mood” at 14 mg nicotine relative
to placebo.
Effects of nicotine on responses to low dose of ethanol
To determine the effects of nicotine pretreatment on
responses to alcohol, change scores were calculated using
measures obtained immediately before and after the
required alcohol beverage. Nicotine (14 mg) increased
ratings of ARCI PCAG [F(2, 34)=4.37, p=0.020], indicat-
ing an increase post-alcohol on ratings of sedation. This
effect was apparent in both men and women. Nicotine did
not change responses to alcohol (0.2 g/kg) on other mea-
sures, and it did not alter blood alcohol levels. Regardless
of nicotine pretreatment or sex, alcohol appeared to in-
crease heart rate and ratings of “want more” (i.e., scores
increased from pre- to post-alcohol in all three patch
conditions in both men and women).
Discussion
In this paper, we report several interesting findings on the
effects of transdermal nicotine on alcohol consumption in
men and women. First, nicotine had differential effects on
alcohol consumption in men and women. In men, nicotine
(14 mg) increased alcohol consumption, whereas, in
women this dose of nicotine decreased alcohol consump-
tion. These effects of nicotine on alcohol choice became
more apparent when the data from individuals who ex-
perienced nausea were removed from the analysis. Second,
the sex differences in the effects of nicotine were especially
apparent when the “cost” of the alcohol was varied. In men,
nicotine most clearly increased alcohol consumption when
the drinks were ‘expensive’, i.e., when participants were
required to pay twice the estimated worth of the drink. In
contrast, nicotine most clearly decreased alcohol consump-
tion in women when the cost was low. Third, nicotine alone
increased ratings of “arousal” in men, whereas, it decreased
ratings of “positive mood” in women.
This study used a recently developed procedure to assess
the effects of nicotine on alcohol consumption (Young et al.
2005), in which the equivalent monetary value of a
standard drink was individually determined for each
participant. This approach addressed the problem that the
value of a drink varies across individuals: a fixed amount
might have been too high for some participants and too low
for others. The sensitivity of this measure was further
enhanced by allowing participants to choose between
Fig. 3 Mean±SEM POMS ratings of “Arousal” in men (n=12) and
women (n=7) not made nauseous by nicotine administration.
* indicates significant difference from placebo. # indicates significant
difference between men and women
Fig. 4 Mean±SEM POMS ratings of “Positive mood” in men
(n=12) and women (n=7) not made nauseous by nicotine
administration. *indicates significant difference from placebo.
# indicates significant difference between men and women
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alcohol and alternative rewards of varying values. The
alternative rewards were tokens, exchangeable for money,
which varied from half (two tokens) to double (eight
tokens) the subject’s individualized value for a standard
drink. As expected, participants chose alcohol more often
when the alternative reward was small, showing that they
were sensitive to changes in the experimental contingen-
cies. Interestingly, there were relationships between the
effects of nicotine and the value of the alternative reward,
which differed in men and women. Whereas in men
nicotine increased the choice of the “expensive” eight-
token drinks, the drug decreased the consumption of the
“cheap” two-token drinks in women. These findings
further indicate that different factors control alcohol
consumption in men and women.
Our findings are consistent with several past reports on
the effects of nicotinic manipulations on alcohol consump-
tion in both humans and laboratory animals (Barrett et al.
2006; Perkins et al. 2000; Potthoff et al. 1983; Smith et al.
1999). Perkins et al. (2000) reported that male, but not
female, smokers consumed less alcohol after overnight
abstinence from smoking. This is consistent with the
idea that nicotine increases alcohol consumption in men.
However, there were many methodological differences
between Perkins et al. (2000) and the present studies,
including the manner of administering nicotine (smoked vs
transdermal and acute withdrawal vs acute administration).
The present results are also consistent with the finding of
Barrett et al. (2006) that light smoking men consumed
more alcohol after smoking nicotine-containing, but not
denicotinized, cigarettes. However, our study also included
women and showed that the effects of nicotine on alcohol
consumption may be sex-specific. Our results are also
consistent with preclinical studies in which both acute and
chronic administration of nicotine increased alcohol con-
sumption (Blomqvist et al. 1996; Le et al. 2000; Potthoff et
al. 1983; Smith et al. 1999). Sex differences were not
examined in these animal studies, although the effects of
nicotine alone are known to differ in male and female rats
(Pogun 2001).
This study also provided information on the direct
effects of nicotine on mood and physiological state, and
these effects may shed light on the changes in alcohol
consumption. First, nicotine (14 mg) produced subjective
ratings of nausea in about 42% of this light smoking
sample, at about equal rates in men and women. This effect
is consistent with previous studies in which nicotine was
administered to ‘chippers’ (Kalman 2002). Second, nico-
tine produced differential effects on mood in men and
women. Men reported increased ratings of arousal, and
women reported decreased ratings of positive mood.
Interestingly, these mood effects in men and women may
have influenced participants’ choice of alcohol in the latter
part of the session. That is, feeling stimulated (in men) may
increase alcohol preference and perhaps may reduce the
inhibitory influence of the cost of a drink. In contrast, the
decreases in ratings of positive mood may have dampened
preference for alcohol in women.
We also found that nicotine increased the acute sedative-
like effects of alcohol in both men and women. Because
this interaction was not sex-specific, it cannot simply
account for the observed changes in alcohol consumption.
However, this interaction can be compared to other recent
reports on nicotine–alcohol interactions (Kouri et al. 2004;
Perkins et al. 2000). In the Perkins et al. (2000) study,
moderate smokers experienced less sedation from alcohol
after normal smoking compared to overnight smoking
abstinence, which is not consistent with our findings.
However, Kouri et al. (2004) found, as we did, that nicotine
(21 mg) increased the sedative-like effects of alcohol (0.4
and 0.7 g/kg) in moderate smokers. In that study, nicotine
also increased reports of euphoria and “feeling drunk.” We
did not measure ‘feeling drunk’ in an effort to maintain the
drug blinding. The enhancement of alcohol-induced
euphoria in the Kouri et al. study may be related to the
higher doses of nicotine and alcohol used, level of partic-
ipants’ smoking, or time after drinking when subjective
effects were measured.
There are at least two possible explanations for the
interaction between nicotine and alcohol consumption.
First, nicotine appears to enhance the incentive properties
of both unconditioned and conditioned reinforcers, perhaps
through its effects on dopamine (Donny et al. 2003;
Olausson et al. 2004; Rice and Cragg 2004; Zhang and
Sulzer 2004). In rats, nicotine increased responses to both
an unconditioned visual reinforcer (Donny et al. 2003) and
a conditioned auditory reinforcer (Olausson et al. 2004).
Thus, at least in men, nicotine appeared to enhance the
reinforcing effects of alcohol in this study. Second, it is
possible that the nicotine-induced changes in mood states
altered the motivation to drink. This possibility could be
examined in future studies where mood states are varied
through non-pharmacological means.
It is possible that these different effects on men and
women may not have resulted from a direct effect of
gender, but were related to other sex differences such as
body composition. However, neither body weight nor BMI
were correlated with nicotine-induced nausea, or with
mood changes after nicotine. Men were significantly older
than women and there were some differences in prior drug
use. Additionally, it is possible that different social factors
influence alcohol consumption in men and women.
Perhaps, women feel less comfortable consuming alcohol
in the laboratory environment while experiencing the sub-
jective effects of unknown drug. Whatever the underlying
mechanisms, this is an interesting example of differential
effects of a psychoactive drug in men and women, and
supports the recognized need for more research on sex
differences in the effects of drugs of abuse [(Roth et al.
2004; Terner and de Wit (2006)].
The study had both strengths and limitations. The
strengths were the inclusion of men and women, the use of
two doses of nicotine, the use of transdermal nicotine to
isolate the pharmacological from conditioned effects of
nicotine, and the use of a sensitive measure of alcohol
consumption. The limitations relate primarily to the subject
sample. First, this study used a small sample size, and
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many subjects were excluded from the data analysis due to
nausea. In addition, these results, obtained with light
smokers, may not be generalizable to the broader popula-
tion of smokers. Our rationale for recruiting light smokers
was to minimize the influence of tolerance and depen-
dence, albeit at the cost of the high incidence of nicotine-
induced nausea. Similarly, this study used light social
drinkers, and it is not known whether other effects would
be observed with heavier habitual drinkers. Finally, in our
study design we were only able to examine the effects of
nicotine on responses to alcohol for a short period of time
(i.e., soon after the first required drink). The effects of
nicotine later in the time–effect curve of alcohol may yield
different results.
This study demonstrates that nicotine, in the absence of
sensory cues associated with smoking, has differential
effects on alcohol consumption in men and women.
Specifically, nicotine increased alcohol consumption in
men and decreased it in women. This finding in men is
consistent with earlier reports of nicotine-induced increases
in alcohol consumption in both men and laboratory
animals. However, the decreased consumption in women
is a novel finding. The present study also suggested that
nicotine has differential effects on the subjective responses
to alcohol in men and women. These interesting findings
lay the groundwork for future studies investigating the
mechanisms underlying these effects.
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